Table 3.
Human Growth Hormone was measured in blood and urine at the same time from healthy donors.
Healthy Donor hGH + |
Blood (ng/ml) |
Direct Measurement in Urine by the Immunoassay¶ (ng/ml) |
Particle Eluate (ng/ml) |
Calculated actual urine concentration of hGH following nanoparticles harvesting (Particle Eluate / Concentration Factor) (pg/ml) |
---|---|---|---|---|
1 | 2.830 | <0.050 | 0.107 | 0.973 |
2 | 0.095 | <0.050 | 0.056 | 0.509 |
3 | 10.136 | <0.050 | 0.078 | 0.100 |
4 | 1.880 | <0.050 | 0.058 | 0.527 |
4 repeat | 2.04 | <0.050 | 0.063 | 0.572 |
Measurements were done using the Immulite hGH serum Immunoassay (Siemens) with a lower detection limit of 50 pg/ml and a linear range of 50 pg-40 ng per ml.
Prior to nanoparticle sequestration of hGH from the urine, the concentration of hGH in all urine samples was below the detection limit (<0.050 ng/mL) of the immulite assay.
The actual concentration in urine was calculated as (particle eluate concentration) / CF, where CF is the Concentration Factor = (Starting volume of urine) / (Volume of eluate) = 33ml/0.3 ml = 110.